MedPath

A randomised controlled trial of nitric oxide administration during cardiopulmonary bypass in neonates undergoing Arterial Switch Operation for repair of transposition of the great arteries.

Not Applicable
Recruiting
Conditions
congenital heart disease
transposition of the great arteries
Surgery - Other surgery
Cardiovascular - Other cardiovascular diseases
Reproductive Health and Childbirth - Complications of newborn
Registration Number
ACTRN12618000089235
Lead Sponsor
Christopher James
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
800
Inclusion Criteria

•Neonate diagnosed with TGA requiring Arterial Switch Operation
•Consent of parents/guardian.

Exclusion Criteria

•Signs of persistently elevated pulmonary vascular resistance preoperatively requiring iNO or preoperative use of drugs involved in the NO pathway, such as nitro-glycerine, sildenafil
•Requirement for ECLS prior to surgery
•Concurrent viral or bacterial acute or chronic infection, including pulmonary conditions such as pneumonia
•Pre-operative acute respiratory distress syndrome
•Cardiac arrest prior to surgery
•Prior surgical exposure to cardio-pulmonary bypass

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite primary outcome: Incidence of post-operative: cardiac arrest, delayed sternal closure, need for extracorporeal membranous oxygenation (ECMO), or death.[Hospital discharge]
Secondary Outcome Measures
NameTimeMethod
ength of stay in ICU as assessed from review of the medical records[date of discharge from PICU];length of hospital stay as assessed from review of the medical records [hospital discharge date];ventilator free days as assessed from review of the medical records[date of discharge from PICU];inotrope free days as assessed from review of the medical records [date of discharge from PICU];nitric oxide free days as assessed from review of the medical records[date of discharge from PICU];dialysis free days as assessed from review of the medical records[date of discharge from PICU];ECMO free days as assessed from review of the medical records [date of discharge from PICU];days with open sternum as assessed from review of the medical records [date of discharge from PICU]
© Copyright 2025. All Rights Reserved by MedPath